Avant Diagnostics Simultaneously Completes Acquisitions of Amarantus Diagnostics and Theranostics Health

Avant Diagnostics, Inc. (OTCQB:  AVDX), an innovative molecular diagnostics company, today announced it has completed the acquisition of Amarantus Diagnostics, Inc., a wholly-owned subsidiary of Amarantus BioScience Holdings, Inc. (OTCQX:  AMBS) and the business of Theranostics Health, Inc.

To read the full press release: Avant DX acquires Amarantus DX and Theranostics Health